XT
AMRX icon

XTX Topco’s Amneal Pharmaceuticals AMRX Stock Holding History

XTX Topco’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$434K Buy
25,084
+6,652
+36% +$91.2K 0.01% 2588
2026
Q1 		$229K Sell
18,432
-3,362
-15% -$45.1K ﹤0.01% 2742
2025
Q4 		$275K Buy
+21,794
New +$249K 0.01% 2155
2025
Q3 		– Sell
-33,918
Closed -$274K – 2524
2025
Q2 		$274K Sell
33,918
-48,358
-59% -$365K 0.01% 1501
2025
Q1 		$689K Buy
82,276
+43,221
+111% +$361K 0.04% 789
2024
Q4 		$309K Buy
39,055
+16,845
+76% +$141K 0.03% 1188
2024
Q3 		$185K Sell
22,210
-10,062
-31% -$78.7K 0.01% 1469
2024
Q2 		$205K Sell
32,272
-2,130
-6% -$13.5K 0.02% 1223
2024
Q1 		$208K Sell
34,402
-14,990
-30% -$84.5K 0.03% 1140
2023
Q4 		$300K Buy
49,392
+7,114
+17% +$31.7K 0.07% 620
2023
Q3 		$178K Buy
42,278
+9,743
+30% +$36.3K 0.03% 1054
2023
Q2 		$101K Sell
32,535
-142,965
-81% -$305K 0.02% 1165
2023
Q1 		$244K Sell
175,500
-16,002
-8% -$31.9K 0.05% 803
2022
Q4 		$381K Buy
+191,502
New +$429K 0.08% 435
2022
Q1 		– Sell
-23,742
Closed -$114K – 660
2021
Q4 		$114K Buy
23,742
+11,369
+92% +$56.7K 0.06% 447
2021
Q3 		$66K Sell
12,373
-12,130
-50% -$61.1K 0.02% 586
2021
Q2 		$125K Buy
+24,503
New +$139K 0.04% 631

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

XTX Topco's AMRX Position: Q2 2026 in Review

XTX Topco increased its Amneal Pharmaceuticals (AMRX) stake by 36% in Q2 2026, buying an estimated $91.2K and bringing the position to 25,084 shares worth $434K. The position accounts for 0.01% of the portfolio, ranked #2588.

XTX Topco first reported a position in AMRX in Q2 2021 and has held it in 17 quarters since. The position peaked at $689K in Q1 2025. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • XTX Topco held 25,084 shares of Amneal Pharmaceuticals worth $434K as of Q2 2026.
  • XTX Topco bought 6,652 Amneal Pharmaceuticals shares in Q2 2026, an estimated $91.2K.
  • Amneal Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2588 holding.
  • XTX Topco first reported a position in Amneal Pharmaceuticals in Q2 2021 and has held it in 17 quarters since.
  • XTX Topco's Amneal Pharmaceuticals position peaked at $689K in Q1 2025.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.